Artificial Intelligence

Spatineo launches an AI-powered search tool to help GIS professionals find spatial data in minutes, not days, tackling a costly industry-wide problem.

Singapore's top agencies win awards for using geospatial AI to transform urban planning, transport, and water management, creating a more resilient city.

A new anti-cheat system promises fair tables and real value for no-deposit bonuses, but can it solve crypto poker's deep-rooted integrity crisis?

ENET launches a new 1.6T optical transceiver to tackle the data bottleneck in AI, but faces a market of giants and looming technological shifts.

Praxis Solutions' new WealthHawk platform uses AI to find clients at key life events, aiming to end cold calling and solve the organic growth puzzle.

Thinkific reports strong 2025 revenue and a return to profitability, betting its future on enterprise clients and its new 'Thinker' AI platform.

After its public debut, BBOT unveils exciting early data from three unique cancer drugs, including a first in pancreatic cancer, backed by a strong cash runway.

NeuroPace will present its RNS System at the Leerink conference, a key moment for the company to showcase its epilepsy treatment to top investors.

Digital accessibility leader AudioEye reports record 2025 earnings and unveils a next-gen platform promising enhanced legal protection for businesses.

aTyr Pharma heads to a crucial FDA meeting for its lung drug efzofitimod, which missed its main goal but showed significant patient quality-of-life gains.

The data center giant raises major capital to double its capacity, targeting the explosive growth in AI and cloud computing. Here's what it means.

Weebit Nano's advanced memory is at the heart of a South Korean national program aiming to revolutionize AI with ultra-low-power compute-in-memory chips.

As Hyperfine preps its 2025 results, investors and clinicians watch to see if its portable Swoop MRI can translate clinical promise into financial success.

NextCure accelerates its high-stakes ovarian cancer drug trial, but with cash dwindling, can it reach the finish line before time runs out?

Inuvo's stock faces uncertainty as a strategic pivot causes a steep Q4 revenue drop, betting its future on its privacy-focused IntentKey AI technology.

With a strong cash position, ArriVent pushes its lead lung cancer drug toward a mid-2026 data readout while building a new pipeline in ADCs.

Luminys Systems Corp. unveils its Vertical Experience Center, shifting from generic products to tailored AI security solutions for retail and education.

A new partnership aims to revolutionize smart glasses by moving AI off the cloud, promising unparalleled privacy and performance. Is this the end of Big Tech's data grip?

Scientists find herpes melts the inside of our cells to replicate faster, a discovery that could revolutionize treatments for a host of viral diseases.

A new partnership integrates conversational AI with deep EHR analysis, promising to save doctors time, improve diagnoses, and boost hospital revenue.